A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma.

Jourdan, Eric

A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma. [electronic resource] - Leukemia & lymphoma Sep 2014 - 2013-7 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study

1029-2403

10.3109/10428194.2013.861066 doi


Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Female
Humans
Indoles--administration & dosage
Male
Middle Aged
Multiple Myeloma--drug therapy
Protein Kinase Inhibitors--administration & dosage
Retreatment
Treatment Outcome